Facebook
Twitter
LinkedIn
Forward
A Closer Look at Psoriasis, Beyond the Skin
Thursday, March 20, 2025 at 2-3pm ET Pricing: Free for Members and Non-Members
Please note that this session is not accredited for continuing pharmacy education credit.
Program Description
Psoriasis is more than a skin disease. It is a chronic, inflammatory, immunologic condition that primarily manifests on the skin, the body's largest organ. If not properly treated, uncontrolled psoriasis can induce inflammatory processes beyond the skin and may lead to comorbid disease. Comorbidities that may impact psoriasis patients such as psoriatic arthritis (PsA), cardiovascular disease, metabolic syndrome, inflammatory bowel disease (IBD), depression and others add burden to the entire healthcare system and adversely impact patient outcomes.
Learning Objectives
- Explain the pathophysiology and epidemiology of psoriasis (PsO) and the interrelationship of the inflammatory pathways associated with comorbidities beyond the skin.
- Understand the PsO-related physical (e.g., PsA, IBD, CV disease) and psychological (e.g., depression) comorbidities.
- Understand the benefits to payers and patients by achieving and maintaining treatment targets for PsO.
- Describe the clinical rationale for early use of advanced systemic therapies in moderate to severe psoriasis patients.
This webinar is sponsored, developed, and presented by the sponsor. The content of this Science & Innovation Webinar and opinions expressed by the presenters are those of the sponsor or presenters and not of AMCP.
Sponsored by:
For individuals from the media/press interested in attending, please email media@amcp.org.
Speaker:
Harrison Nguyen, MD, MBA, DTM&H, FAAD
Clinical Investigator/Co-Fellowship Director of Clinical Research
Center for Clinical Studies
Clinical Assistant Professor of Dermatology and Health Economics
University of Houston College of Medicine
Harrison P. Nguyen, MD, MBA, MPH, DTM&H, FAAD is a double board-certified Dermatologist/Mohs Micrographic Surgeon and NIH-funded clinical researcher in Houston, Texas. He serves as Clinical Investigator/Co-Fellowship Director of Clinical Research at the Center for Clinical Studies (the largest dermatology clinical research center in Texas) and Clinical Assistant Professor of Dermatology and Health Economics at the University of Houston College of Medicine.
He completed a Fellowship in Dermatologic Surgery at the University of Pennsylvania, where he was an Associate Fellow at the Leonard Davis Institute of Health Economics. He previously was Chief Resident in Dermatology at the Emory University School of Medicine and a Postdoctoral Fellow in the Department of Biomedical Engineering at the Georgia Institute of Technology. Prior to joining Emory/GT, Dr. Nguyen was an independent consultant to several Fortune 500 pharmaceutical companies and early-stage healthcare start-ups. His most high-profile start-up client achieved unicorn status in February 2021.
Dr. Nguyen graduated with honors from Rice University, where he was an All-Conference Linebacker for the Rice Owls Football Team. He continued to earn his MD from Baylor College of Medicine, MBA from the Yale School of Management, MPH from the Yale School of Public Health, and DTM&H from the National School of Tropical Medicine. He is a member of the Board of Directors for the American Society of Dermatologic Surgery/Association, leads the American Academy of Dermatology's Health Policy Research Group, and has been a Visiting Professor at the Oregon Health & Science University and the Baylor College of Medicine. He serves on the Editorial Boards of the Journal of Clinical and Aesthetic Dermatology and Journal of Cutaneous Medicine and has authored over 50 PubMed-indexed scientific articles.
Price
Required Hardware/software
AMCP Learn utilizes the Zoom Webinars platform for live webinars. For a smoother experience joining the webinar, please install the Zoom desktop client or mobile app prior to the start time. If you experience technical issues joining the webinar, please email webinars@amcp.org.